Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma.
AuthorsLim, Kok Haw Jonathan
Lorigan, Paul C
AffiliationDepartment of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
MetadataShow full item record
AbstractAgreement on the utility of imaging follow-up in patients with high-risk melanoma is lacking. A UK consensus statement recommends a surveillance schedule of CT or positron-emission tomography-CT and MRI brain (every 6 months for 3 years, then annually in years 4 and 5) as well as clinical examination for high-risk resected Stages II and III cutaneous melanoma. Our aim was to assess patterns of relapse and whether imaging surveillance could be of clinical benefit.
CitationContemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma. 2018, 3(2): e000317 ESMO Open